CDKN1A and malignant colon neoplasm: Upregulation of TRAIL receptors by indirubins has also been seen in hepatoma, cervical, colon cancer and melanoma cells [47,56,57], whereas upregulation of p21 by indirubin was reported in human laryngeal carcinoma cells [58].